Summary

The global Recombinant Human GMF-β market size is predicted to grow from US$ 107 million in 2025 to US$ 158 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
GMF-beta belongs to the actin-binding ADF/cofilin family of proteins. It contains an ADF-H domain, but crystallographic and NMR studies have shown structural differences between the human and mouse ADF-H domains. It was originally identified as a growth gamma differentiation factor acting on neurons and glial cells. It has also been shown to function intracellularly as a regulator of MAP kinase signaling.
United States market for Recombinant Human GMF-β is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Recombinant Human GMF-β is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Recombinant Human GMF-β is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Recombinant Human GMF-β players cover Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Recombinant Human GMF-β Industry Forecast” looks at past sales and reviews total world Recombinant Human GMF-β sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human GMF-β sales for 2025 through 2031. With Recombinant Human GMF-β sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human GMF-β industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human GMF-β landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Human GMF-β portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human GMF-β market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human GMF-β and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human GMF-β.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human GMF-β market by product type, application, key players and key regions and countries.
Segmentation by Type:
Purity＜95%
Purity ≥95%
Segmentation by Application:
University
Research Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Human GMF-β Market Size (2020-2031)
2.1.2 Recombinant Human GMF-β Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Recombinant Human GMF-β by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Human GMF-β Segment by Type
2.2.1 Purity＜95%
2.2.2 Purity ≥95%
2.3 Recombinant Human GMF-β Market Size by Type
2.3.1 Recombinant Human GMF-β Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
2.4 Recombinant Human GMF-β Segment by Application
2.4.1 University
2.4.2 Research Center
2.5 Recombinant Human GMF-β Market Size by Application
2.5.1 Recombinant Human GMF-β Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
3 Recombinant Human GMF-β Market Size by Player
3.1 Recombinant Human GMF-β Market Size Market Share by Player
3.1.1 Global Recombinant Human GMF-β Revenue by Player (2020-2025)
3.1.2 Global Recombinant Human GMF-β Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Human GMF-β Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Human GMF-β by Region
4.1 Recombinant Human GMF-β Market Size by Region (2020-2025)
4.2 Global Recombinant Human GMF-β Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Human GMF-β Market Size Growth (2020-2025)
4.4 APAC Recombinant Human GMF-β Market Size Growth (2020-2025)
4.5 Europe Recombinant Human GMF-β Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Human GMF-β Market Size Growth (2020-2025)
5 Americas
5.1 Americas Recombinant Human GMF-β Market Size by Country (2020-2025)
5.2 Americas Recombinant Human GMF-β Market Size by Type (2020-2025)
5.3 Americas Recombinant Human GMF-β Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human GMF-β Market Size by Region (2020-2025)
6.2 APAC Recombinant Human GMF-β Market Size by Type (2020-2025)
6.3 APAC Recombinant Human GMF-β Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Human GMF-β Market Size by Country (2020-2025)
7.2 Europe Recombinant Human GMF-β Market Size by Type (2020-2025)
7.3 Europe Recombinant Human GMF-β Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Human GMF-β by Region (2020-2025)
8.2 Middle East & Africa Recombinant Human GMF-β Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Human GMF-β Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Human GMF-β Market Forecast
10.1 Global Recombinant Human GMF-β Forecast by Region (2026-2031)
10.1.1 Global Recombinant Human GMF-β Forecast by Region (2026-2031)
10.1.2 Americas Recombinant Human GMF-β Forecast
10.1.3 APAC Recombinant Human GMF-β Forecast
10.1.4 Europe Recombinant Human GMF-β Forecast
10.1.5 Middle East & Africa Recombinant Human GMF-β Forecast
10.2 Americas Recombinant Human GMF-β Forecast by Country (2026-2031)
10.2.1 United States Market Recombinant Human GMF-β Forecast
10.2.2 Canada Market Recombinant Human GMF-β Forecast
10.2.3 Mexico Market Recombinant Human GMF-β Forecast
10.2.4 Brazil Market Recombinant Human GMF-β Forecast
10.3 APAC Recombinant Human GMF-β Forecast by Region (2026-2031)
10.3.1 China Recombinant Human GMF-β Market Forecast
10.3.2 Japan Market Recombinant Human GMF-β Forecast
10.3.3 Korea Market Recombinant Human GMF-β Forecast
10.3.4 Southeast Asia Market Recombinant Human GMF-β Forecast
10.3.5 India Market Recombinant Human GMF-β Forecast
10.3.6 Australia Market Recombinant Human GMF-β Forecast
10.4 Europe Recombinant Human GMF-β Forecast by Country (2026-2031)
10.4.1 Germany Market Recombinant Human GMF-β Forecast
10.4.2 France Market Recombinant Human GMF-β Forecast
10.4.3 UK Market Recombinant Human GMF-β Forecast
10.4.4 Italy Market Recombinant Human GMF-β Forecast
10.4.5 Russia Market Recombinant Human GMF-β Forecast
10.5 Middle East & Africa Recombinant Human GMF-β Forecast by Region (2026-2031)
10.5.1 Egypt Market Recombinant Human GMF-β Forecast
10.5.2 South Africa Market Recombinant Human GMF-β Forecast
10.5.3 Israel Market Recombinant Human GMF-β Forecast
10.5.4 Turkey Market Recombinant Human GMF-β Forecast
10.6 Global Recombinant Human GMF-β Forecast by Type (2026-2031)
10.7 Global Recombinant Human GMF-β Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Recombinant Human GMF-β Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Information
11.1.2 Thermo Fisher Scientific Inc. Recombinant Human GMF-β Product Offered
11.1.3 Thermo Fisher Scientific Inc. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Inc. Main Business Overview
11.1.5 Thermo Fisher Scientific Inc. Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Recombinant Human GMF-β Product Offered
11.2.3 Bio-Techne Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Scientists Helping Scientists
11.3.1 Scientists Helping Scientists Company Information
11.3.2 Scientists Helping Scientists Recombinant Human GMF-β Product Offered
11.3.3 Scientists Helping Scientists Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Scientists Helping Scientists Main Business Overview
11.3.5 Scientists Helping Scientists Latest Developments
11.4 Abcam Limited
11.4.1 Abcam Limited Company Information
11.4.2 Abcam Limited Recombinant Human GMF-β Product Offered
11.4.3 Abcam Limited Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Abcam Limited Main Business Overview
11.4.5 Abcam Limited Latest Developments
11.5 FUJIFILM Irvine Scientific
11.5.1 FUJIFILM Irvine Scientific Company Information
11.5.2 FUJIFILM Irvine Scientific Recombinant Human GMF-β Product Offered
11.5.3 FUJIFILM Irvine Scientific Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 FUJIFILM Irvine Scientific Main Business Overview
11.5.5 FUJIFILM Irvine Scientific Latest Developments
11.6 BD Biosciences
11.6.1 BD Biosciences Company Information
11.6.2 BD Biosciences Recombinant Human GMF-β Product Offered
11.6.3 BD Biosciences Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 BD Biosciences Main Business Overview
11.6.5 BD Biosciences Latest Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Information
11.7.2 Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Product Offered
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.7.5 Bio-Rad Laboratories, Inc. Latest Developments
11.8 BPS Bioscience, Inc.
11.8.1 BPS Bioscience, Inc. Company Information
11.8.2 BPS Bioscience, Inc. Recombinant Human GMF-β Product Offered
11.8.3 BPS Bioscience, Inc. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BPS Bioscience, Inc. Main Business Overview
11.8.5 BPS Bioscience, Inc. Latest Developments
11.9 Elabscience
11.9.1 Elabscience Company Information
11.9.2 Elabscience Recombinant Human GMF-β Product Offered
11.9.3 Elabscience Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Elabscience Main Business Overview
11.9.5 Elabscience Latest Developments
11.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
11.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
11.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Product Offered
11.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business Overview
11.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
11.11 Abbkine
11.11.1 Abbkine Company Information
11.11.2 Abbkine Recombinant Human GMF-β Product Offered
11.11.3 Abbkine Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Abbkine Main Business Overview
11.11.5 Abbkine Latest Developments
11.12 Beijing Biocreative Technology Co., Ltd.
11.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
11.12.2 Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Product Offered
11.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Beijing Biocreative Technology Co., Ltd. Main Business Overview
11.12.5 Beijing Biocreative Technology Co., Ltd. Latest Developments
11.13 Shanghai Yaji Biotechnology Co., Ltd.
11.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
11.13.2 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Product Offered
11.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Shanghai Yaji Biotechnology Co., Ltd. Main Business Overview
11.13.5 Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
11.14 Cellverse Co., Ltd.
11.14.1 Cellverse Co., Ltd. Company Information
11.14.2 Cellverse Co., Ltd. Recombinant Human GMF-β Product Offered
11.14.3 Cellverse Co., Ltd. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Cellverse Co., Ltd. Main Business Overview
11.14.5 Cellverse Co., Ltd. Latest Developments
11.15 Dalian Meilun Biotech Co., Ltd.
11.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
11.15.2 Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Product Offered
11.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Dalian Meilun Biotech Co., Ltd. Main Business Overview
11.15.5 Dalian Meilun Biotech Co., Ltd. Latest Developments
11.16 Sino Biological,Inc.
11.16.1 Sino Biological,Inc. Company Information
11.16.2 Sino Biological,Inc. Recombinant Human GMF-β Product Offered
11.16.3 Sino Biological,Inc. Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Sino Biological,Inc. Main Business Overview
11.16.5 Sino Biological,Inc. Latest Developments
11.17 Prospec-Tany Technogene Ltd
11.17.1 Prospec-Tany Technogene Ltd Company Information
11.17.2 Prospec-Tany Technogene Ltd Recombinant Human GMF-β Product Offered
11.17.3 Prospec-Tany Technogene Ltd Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Prospec-Tany Technogene Ltd Main Business Overview
11.17.5 Prospec-Tany Technogene Ltd Latest Developments
11.18 ENZO
11.18.1 ENZO Company Information
11.18.2 ENZO Recombinant Human GMF-β Product Offered
11.18.3 ENZO Recombinant Human GMF-β Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 ENZO Main Business Overview
11.18.5 ENZO Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Recombinant Human GMF-β Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Recombinant Human GMF-β Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Purity＜95%
Table 4. Major Players of Purity ≥95%
Table 5. Recombinant Human GMF-β Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Recombinant Human GMF-β Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
Table 8. Recombinant Human GMF-β Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Recombinant Human GMF-β Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
Table 11. Global Recombinant Human GMF-β Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Recombinant Human GMF-β Revenue Market Share by Player (2020-2025)
Table 13. Recombinant Human GMF-β Key Players Head office and Products Offered
Table 14. Recombinant Human GMF-β Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Recombinant Human GMF-β Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Recombinant Human GMF-β Market Size Market Share by Region (2020-2025)
Table 19. Global Recombinant Human GMF-β Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Recombinant Human GMF-β Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Recombinant Human GMF-β Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Recombinant Human GMF-β Market Size Market Share by Country (2020-2025)
Table 23. Americas Recombinant Human GMF-β Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
Table 25. Americas Recombinant Human GMF-β Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
Table 27. APAC Recombinant Human GMF-β Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Recombinant Human GMF-β Market Size Market Share by Region (2020-2025)
Table 29. APAC Recombinant Human GMF-β Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Recombinant Human GMF-β Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Recombinant Human GMF-β Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Recombinant Human GMF-β Market Size Market Share by Country (2020-2025)
Table 33. Europe Recombinant Human GMF-β Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Recombinant Human GMF-β Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Recombinant Human GMF-β Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Recombinant Human GMF-β Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Recombinant Human GMF-β Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Recombinant Human GMF-β
Table 39. Key Market Challenges & Risks of Recombinant Human GMF-β
Table 40. Key Industry Trends of Recombinant Human GMF-β
Table 41. Global Recombinant Human GMF-β Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Recombinant Human GMF-β Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Recombinant Human GMF-β Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Recombinant Human GMF-β Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Thermo Fisher Scientific Inc. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 46. Thermo Fisher Scientific Inc. Recombinant Human GMF-β Product Offered
Table 47. Thermo Fisher Scientific Inc. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Thermo Fisher Scientific Inc. Main Business
Table 49. Thermo Fisher Scientific Inc. Latest Developments
Table 50. Bio-Techne Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 51. Bio-Techne Recombinant Human GMF-β Product Offered
Table 52. Bio-Techne Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Bio-Techne Main Business
Table 54. Bio-Techne Latest Developments
Table 55. Scientists Helping Scientists Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 56. Scientists Helping Scientists Recombinant Human GMF-β Product Offered
Table 57. Scientists Helping Scientists Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Scientists Helping Scientists Main Business
Table 59. Scientists Helping Scientists Latest Developments
Table 60. Abcam Limited Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 61. Abcam Limited Recombinant Human GMF-β Product Offered
Table 62. Abcam Limited Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Abcam Limited Main Business
Table 64. Abcam Limited Latest Developments
Table 65. FUJIFILM Irvine Scientific Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 66. FUJIFILM Irvine Scientific Recombinant Human GMF-β Product Offered
Table 67. FUJIFILM Irvine Scientific Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. FUJIFILM Irvine Scientific Main Business
Table 69. FUJIFILM Irvine Scientific Latest Developments
Table 70. BD Biosciences Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 71. BD Biosciences Recombinant Human GMF-β Product Offered
Table 72. BD Biosciences Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. BD Biosciences Main Business
Table 74. BD Biosciences Latest Developments
Table 75. Bio-Rad Laboratories, Inc. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 76. Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Product Offered
Table 77. Bio-Rad Laboratories, Inc. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bio-Rad Laboratories, Inc. Main Business
Table 79. Bio-Rad Laboratories, Inc. Latest Developments
Table 80. BPS Bioscience, Inc. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 81. BPS Bioscience, Inc. Recombinant Human GMF-β Product Offered
Table 82. BPS Bioscience, Inc. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. BPS Bioscience, Inc. Main Business
Table 84. BPS Bioscience, Inc. Latest Developments
Table 85. Elabscience Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 86. Elabscience Recombinant Human GMF-β Product Offered
Table 87. Elabscience Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Elabscience Main Business
Table 89. Elabscience Latest Developments
Table 90. Yisheng Biotechnology (Shanghai) Co., Ltd. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 91. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Product Offered
Table 92. Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business
Table 94. Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
Table 95. Abbkine Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 96. Abbkine Recombinant Human GMF-β Product Offered
Table 97. Abbkine Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Abbkine Main Business
Table 99. Abbkine Latest Developments
Table 100. Beijing Biocreative Technology Co., Ltd. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 101. Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Product Offered
Table 102. Beijing Biocreative Technology Co., Ltd. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Beijing Biocreative Technology Co., Ltd. Main Business
Table 104. Beijing Biocreative Technology Co., Ltd. Latest Developments
Table 105. Shanghai Yaji Biotechnology Co., Ltd. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 106. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Product Offered
Table 107. Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Shanghai Yaji Biotechnology Co., Ltd. Main Business
Table 109. Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
Table 110. Cellverse Co., Ltd. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 111. Cellverse Co., Ltd. Recombinant Human GMF-β Product Offered
Table 112. Cellverse Co., Ltd. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Cellverse Co., Ltd. Main Business
Table 114. Cellverse Co., Ltd. Latest Developments
Table 115. Dalian Meilun Biotech Co., Ltd. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 116. Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Product Offered
Table 117. Dalian Meilun Biotech Co., Ltd. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Dalian Meilun Biotech Co., Ltd. Main Business
Table 119. Dalian Meilun Biotech Co., Ltd. Latest Developments
Table 120. Sino Biological,Inc. Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 121. Sino Biological,Inc. Recombinant Human GMF-β Product Offered
Table 122. Sino Biological,Inc. Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Sino Biological,Inc. Main Business
Table 124. Sino Biological,Inc. Latest Developments
Table 125. Prospec-Tany Technogene Ltd Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 126. Prospec-Tany Technogene Ltd Recombinant Human GMF-β Product Offered
Table 127. Prospec-Tany Technogene Ltd Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Prospec-Tany Technogene Ltd Main Business
Table 129. Prospec-Tany Technogene Ltd Latest Developments
Table 130. ENZO Details, Company Type, Recombinant Human GMF-β Area Served and Its Competitors
Table 131. ENZO Recombinant Human GMF-β Product Offered
Table 132. ENZO Recombinant Human GMF-β Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. ENZO Main Business
Table 134. ENZO Latest Developments


List of Figures
Figure 1. Recombinant Human GMF-β Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Human GMF-β Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Recombinant Human GMF-β Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Recombinant Human GMF-β Sales Market Share by Country/Region (2024)
Figure 8. Recombinant Human GMF-β Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Recombinant Human GMF-β Market Size Market Share by Type in 2024
Figure 10. Recombinant Human GMF-β in University
Figure 11. Global Recombinant Human GMF-β Market: University (2020-2025) & ($ millions)
Figure 12. Recombinant Human GMF-β in Research Center
Figure 13. Global Recombinant Human GMF-β Market: Research Center (2020-2025) & ($ millions)
Figure 14. Global Recombinant Human GMF-β Market Size Market Share by Application in 2024
Figure 15. Global Recombinant Human GMF-β Revenue Market Share by Player in 2024
Figure 16. Global Recombinant Human GMF-β Market Size Market Share by Region (2020-2025)
Figure 17. Americas Recombinant Human GMF-β Market Size 2020-2025 ($ millions)
Figure 18. APAC Recombinant Human GMF-β Market Size 2020-2025 ($ millions)
Figure 19. Europe Recombinant Human GMF-β Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Recombinant Human GMF-β Market Size 2020-2025 ($ millions)
Figure 21. Americas Recombinant Human GMF-β Value Market Share by Country in 2024
Figure 22. United States Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Recombinant Human GMF-β Market Size Market Share by Region in 2024
Figure 27. APAC Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
Figure 28. APAC Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
Figure 29. China Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 33. India Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Recombinant Human GMF-β Market Size Market Share by Country in 2024
Figure 36. Europe Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
Figure 37. Europe Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
Figure 38. Germany Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 39. France Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Recombinant Human GMF-β Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Recombinant Human GMF-β Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Recombinant Human GMF-β Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Recombinant Human GMF-β Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 52. APAC Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 53. Europe Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 55. United States Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 56. Canada Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 57. Mexico Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 58. Brazil Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 59. China Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 60. Japan Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 61. Korea Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 63. India Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 64. Australia Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 65. Germany Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 66. France Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 67. UK Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 68. Italy Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 69. Russia Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 70. Egypt Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 71. South Africa Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 72. Israel Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 73. Turkey Recombinant Human GMF-β Market Size 2026-2031 ($ millions)
Figure 74. Global Recombinant Human GMF-β Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Recombinant Human GMF-β Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Recombinant Human GMF-β Market Size 2026-2031 ($ millions)